These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35293054)

  • 1. Health worker perceptions of the impact of COVID-19 on harm reduction services for people who inject drugs.
    Brener L; Horwitz R; Rance J; Caruana T; Bryant J
    Health Soc Care Community; 2022 Nov; 30(6):2320-2329. PubMed ID: 35293054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV Care Continuum Services for People Who Inject Drugs in Kazakhstan During COVID-19: A Qualitative Study of Service Provider Perspectives.
    McCrimmon T; Sundelson A; Darisheva M; Gilbert L; Hunt T; Terlikbayeva A; Primbetova S; El-Bassel N
    Glob Health Sci Pract; 2022 Apr; 10(2):. PubMed ID: 35487549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A qualitative study exploring the impact of the COVID-19 pandemic on People Who Inject Drugs (PWID) and drug service provision in the UK: PWID and service provider perspectives.
    May T; Dawes J; Fancourt D; Burton A
    Int J Drug Policy; 2022 Aug; 106():103752. PubMed ID: 35653821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.
    Thakarar K; Kohut M; Hutchinson R; Bell R; Loeb HE; Burris D; Fairfield KM
    Harm Reduct J; 2022 Jul; 19(1):80. PubMed ID: 35869523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health service utilisation and access for people who inject drugs during COVID-19.
    Efunnuga H; Higgs P; Walker S; O'Keefe D
    Drug Alcohol Rev; 2022 Sep; 41(6):1304-1310. PubMed ID: 35266229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative study.
    Ude M; Behrends CN; Kelly S; Schackman BR; Clear A; Goldberg R; Gelberg K; Kapadia SN
    Harm Reduct J; 2023 Feb; 20(1):12. PubMed ID: 36732773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How has the COVID-19 epidemic affected the risk behaviors of people who inject drugs in a city with high harm reduction service coverage in Vietnam? A qualitative investigation.
    Nguyen TT; Hoang GT; Nguyen DQ; Nguyen AH; Luong NA; Laureillard D; Nagot N; Des Jarlais D; Duong HT; Nham TTT; Khuat OTH; Pham KM; Le MS; Michel L; Rapoud D; Le GM
    Harm Reduct J; 2022 Jan; 19(1):6. PubMed ID: 35090482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
    Davitadze A; Meylakhs P; Lakhov A; King EJ
    Harm Reduct J; 2020 Dec; 17(1):98. PubMed ID: 33298081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs.
    Kesten JM; Holland A; Linton MJ; Family H; Scott J; Horwood J; Hickman M; Telfer M; Ayres R; Hussey D; Wilkinson J; Hines LA
    Int J Drug Policy; 2021 Dec; 98():103391. PubMed ID: 34343945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid evidence review of harm reduction interventions and messaging for people who inject drugs during pandemic events: implications for the ongoing COVID-19 response.
    Wilkinson R; Hines L; Holland A; Mandal S; Phipps E
    Harm Reduct J; 2020 Dec; 17(1):95. PubMed ID: 33261636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia.
    Roxburgh A; Jauncey M; Day C; Bartlett M; Cogger S; Dietze P; Nielsen S; Latimer J; Clark N
    Harm Reduct J; 2021 Feb; 18(1):20. PubMed ID: 33596940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intersecting substance use treatment and harm reduction services: exploring the characteristics and service needs of a community-based sample of people who use drugs.
    Krawczyk N; Allen ST; Schneider KE; Solomon K; Shah H; Morris M; Harris SJ; Sherman SG; Saloner B
    Harm Reduct J; 2022 Aug; 19(1):95. PubMed ID: 36002850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing integrated community-based HIV prevention, harm reduction, and sexual and reproductive health services for women who inject drugs.
    Ayon S; Jeneby F; Hamid F; Badhrus A; Abdulrahman T; Mburu G
    Reprod Health; 2019 May; 16(Suppl 1):59. PubMed ID: 31138238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'They already operated like it was a crisis, because it always has been a crisis': a qualitative exploration of the response of one homeless service in Scotland to the COVID-19 pandemic.
    Parkes T; Carver H; Masterton W; Falzon D; Dumbrell J; Grant S; Wilson I
    Harm Reduct J; 2021 Mar; 18(1):26. PubMed ID: 33658042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "You know, we can change the services to suit the circumstances of what is happening in the world": a rapid case study of the COVID-19 response across city centre homelessness and health services in Edinburgh, Scotland.
    Parkes T; Carver H; Masterton W; Falzon D; Dumbrell J; Grant S; Wilson I
    Harm Reduct J; 2021 Jun; 18(1):64. PubMed ID: 34118942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A qualitative study trialling the acceptability of new hepatitis C prevention messages for people who inject drugs: symbiotic messages, pleasure and conditional interpretations.
    Treloar C; Newland J; Maher L
    Harm Reduct J; 2015 Mar; 12():5. PubMed ID: 25884357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of COVID-19 public health measures on attendance and overdose at supervised injecting facilities in Australia.
    Roxburgh A; Livingston M; Dietze P; Nielsen S; Cogger S; Bartlett M; Day C; Latimer J; Jauncey M; Clark N
    Public Health; 2023 Nov; 224():90-97. PubMed ID: 37742585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of COVID-19 pandemic on provision of sexual and reproductive health services in primary health facilities in Nigeria: a cross-sectional study.
    Adelekan B; Goldson E; Abubakar Z; Mueller U; Alayande A; Ojogun T; Ntoimo L; Williams B; Muhammed I; Okonofua F
    Reprod Health; 2021 Aug; 18(1):166. PubMed ID: 34348757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trust and people who inject drugs: The perspectives of clients and staff of Needle Syringe Programs.
    Treloar C; Rance J; Yates K; Mao L
    Int J Drug Policy; 2016 Jan; 27():138-45. PubMed ID: 26394538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "We were building the plane as we were flying it, and we somehow made it to the other end": syringe service program staff experiences and well-being during the COVID-19 pandemic.
    Wang A; Jawa R; Mackin S; Whynott L; Buchholz C; Childs E; Bazzi AR
    Harm Reduct J; 2022 Jul; 19(1):78. PubMed ID: 35841101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.